Related Experiment Video
Updated: Nov 4, 2025

Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
Hypericin in photobiological assays: An overview
Gislaine Patricia de Andrade1, Thaiza Ferreira Menegassi de Souza1, Giselle Cerchiaro1
1Centro de Ciências Naturais e Humanas (CCNH), Universidade Federal do ABC, Av. dos Estados, 5001, Bairro Bangú, Santo André, SP, Brasil.
Hypericin shows potential in photodynamic therapy (PDT) for cancer and microbial infections. Its effectiveness in PDT applications depends on concentration, light dose, and cell type, influencing cell death mechanisms.
Area of Science:
- Biochemistry
- Photomedicine
- Cell Biology
Background:
- Hypericin is a potent photosensitizer with therapeutic potential.
- Photodynamic therapy (PDT) utilizes photosensitizers for antitumor and antimicrobial applications.
Purpose of the Study:
- To review biological results of hypericin in various photodynamic therapy (PDT) applications.
- To compile and analyze in vitro data on hypericin's efficacy in cancer treatment, microbial photoinactivation, and tissue diagnostics.
Main Methods:
- Compilation and analysis of published in vitro studies on hypericin.
- Evaluation of experimental conditions including hypericin concentration and light dose.
- Assessment of outcomes such as cell death, viability, and proliferation.
Main Results:
- Hypericin demonstrates varying phototoxicity levels based on light dose and concentration.
- Cellular localization and mechanisms of cell death (apoptosis, necrosis) are cell-type dependent.
- Hypericin shows promise in photodynamic cancer treatment and microbial photoinactivation.
Conclusions:
- Hypericin is a versatile photosensitizer for diverse PDT applications.
- Optimizing hypericin concentration and light dose is crucial for therapeutic efficacy.
- Understanding cell-type specific responses is key to maximizing hypericin-based PDT outcomes.
More Related Videos
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016